VEGFR(血管内皮生长因子受体)
VEGFR are receptors for vascular endothelial growth factor and belong to receptor tyrosine kinases.
Products for VEGFR
- Cat.No. 产品名称 Information
- GC17800 (E)-FeCP-oxindole VEGFR-2 inhibitor
- GC13944 (5Z)-7-Oxozeaenol A selective TAK1 inhibitor
- GC11417 SU 4312 A selective dual inhibitor of VEGFR2 and PDGFR
- GC16183 EG00229 An NRP-1 antagonist
- GC13833 BMS-794833 An inhibitor of c-Met and VEGFR2
- GC10758 Tyrphostin 9 An inhibitor of EGF receptor kinase
- GC11555 ZM 323881 HCl A potent and selective VEGFR2 inhibitor
- GC12586 SAR131675 An inhibitor of VEGFR3
-
GC14292
Apatinib Mesylate
A selective VEGFR2 inhibitor
- GC17715 Golvatinib (E7050) A dual inhibitor of c-Met and VEGFR2
- GC12980 CP-673451 A selective PDGFRα/β kinase inhibitor
- GC12531 Cabozantinib malate (XL184) A VEGFR2 inhibitor
- GC11003 PP121 A potent dual inhibitor of tyrosine and phosphoinositide kinases
- GC17651 Sunitinib Sunitinib (SU 11248) 是一种多靶点受体酪氨酸激酶抑制剂,对 VEGFR2 和 PDGFRβ 的 IC50 分别为 80 nM 和 2 nM。 Sunitinib 是一种 ATP 竞争性抑制剂,通过抑制自身磷酸化和随后的 RNase 激活,有效抑制 Ire1α 的自身磷酸化。
- GC10220 TAK-593 TAK-593 是一种有效的 VEGFR 和 PDGFR 家族抑制剂,对 VEGFR1、VEGFR2、VEGFR3、PDFGRα 和 PDFGRβ 的 IC50 分别为 3.2、0.95、1.1、4.3 和 13 nM。
- GC13738 SKLB1002 A VEGFR2 inhibitor
- GC12185 ZM 306416 A VEGF receptor kinase inhibitor
- GC16000 WHI-P180 A multi-kinase inhibitor
- GC15022 Vandetanib (ZD6474) A multi-kinase inhibitor
- GC11763 Telatinib (BAY 57-9352) A multi-kinase inhibitor
- GC11372 Dovitinib Dilactic acid FLT3 inhibitor
- GC12216 Axitinib (AG 013736) A VEGFR inhibitor
- GC12730 Pazopanib Hydrochloride A multi-kinase inhibitor
- GC15818 RAF265 A B-Raf and VEGFR2 inhibitor
- GC12590 KRN 633 A VEGF receptor tyrosine kinase inhibitor
- GC14396 Ponatinib (AP24534) An inhibitor of native and mutant Bcr-Abl
- GC16732 TSU-68 (SU6668,Orantinib) An inhibitor of select receptor tyrosine kinases
- GC17955 Vatalanib (PTK787) 2HCl A potent and selective VEGF receptor inhibitor
- GC14238 Brivanib Alaninate (BMS-582664) A prodrug form of brivanib
- GC15735 Foretinib (GSK1363089) A broad-spectrum tyrosine kinase inhibitor
- GC11336 Motesanib Diphosphate (AMG-706) A multikinase inhibitor
- GC13598 MGCD-265 A c-Met and VEGFR2 inhibitor
-
GC15454
Lenvatinib (E7080)
An inhibitor of VEGFR2 and VEGFR3
- GC14957 OSI-930 A dual inhibitor of Kit and VEGFR2
- GC11692 Brivanib (BMS-540215) A VEGFR1, VEGFR2, and FGFR1 inhibitor
- GC12036 Tivozanib (AV-951) Tivozanib (AV-951; KRN951) 是一种有效的、选择性的、具有口服活性的 VEGFR 酪氨酸激酶抑制剂,对 VEGFR-1、VEGFR-2、VEGFR-3 的 IC50 分别为 0.21、0.16、0.24 nM。 Tivozanib 抑制肿瘤组织中的血管生成和血管通透性,并显示出抗肿瘤活性。 Tivozanib 具有研究转移性肾细胞癌(RCC)的潜力。
- GC15779 Cabozantinib (XL184, BMS-907351) A VEGFR2 inhibitor
- GC16421 Cediranib (AZD217) An inhibitor of VEGF receptor tyrosine kinases
- GC13547 Dovitinib (TKI-258, CHIR-258) A multi-kinase inhibitor
- GC17958 Linifanib (ABT-869) A dual VEGFR and PDGFR family kinase inhibitor
- GC11666 Ki8751 A potent, orally available VEGFR2 inhibitor
- GC14683 Sunitinib malate A multi-kinase inhibitor
- GC17943 PD 173074 Inhibitor of tyrosine kinase activity of fibroblast growth factor receptors
- GC11705 Nintedanib (BIBF 1120) A VEGFR, FGFR, and PDGFR inhibitor
- GC16499 Sorafenib Tosylate A multi-kinase inhibitor
- GC12776 SKLB610 An inhibitor of VEGFR2
- GC10111 Regorafenib A multi-kinase inhibitor
- GC14464 Vatalanib A potent and selective VEGF receptor inhibitor
- GC12656 ZM323881 A potent and selective VEGFR2 inhibitor
- GC11876 Vandetanib hydrochloride A multi-kinase inhibitor